Pain in photodynamic therapy: mechanism of action and management strategies.

Photodynamic therapy involves administration of a photosensitizing drug and its subsequent activation by irradiation with a light source at wavelengths matching the absorption spectrum of the photosensitizer. In many countries around the world, topical photodynamic therapy has been approved for treatment of cutaneous oncologic conditions such as actinic keratosis, Bowen's disease, and superficial basal cell carcinoma. Multicenter, randomized, controlled studies have confirmed its efficacy and superior cosmetic outcomes compared to conventional therapies. Nevertheless, this therapeutic method presents some adverse effects, such as erythema, edema, pigmentation, pustules, and pain. There is no doubt that pain is the most severe of the adverse effects, being sometimes responsible for definitive treatment interruption. The pain mechanism has not yet been fully understood, which makes complete pain control a challenge to be conquered. In spite of that, this literature review presents some useful pain management strategies as well as the most important pain-related factors in photodynamic therapy.

[1]  G. Magalhães,et al.  Terapia fotodinâmica para tratamento de múltiplas lesões no couro cabeludo na síndrome do nevobasocelular: relato de caso , 2010 .

[2]  Merete Haedersdal,et al.  Morphine gel 0.3% does not relieve pain during topical photodynamic therapy: a randomized, double-blind, placebo-controlled study. , 2006, Acta dermato-venereologica.

[3]  M. Landthaler,et al.  Variable pulsed light is less painful than light‐emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial , 2007 .

[4]  P. Nelemans,et al.  Pain during topical photodynamic therapy: uncomfortable and unpredictable , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  C. Berking,et al.  The Efficacy of Photodynamic Therapy in Actinic Cheilitis of the Lower Lip: A Prospective Study of 15 Patients , 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[6]  M. Ericson,et al.  Pain caused by photodynamic therapy of skin cancer , 2002, Clinical and experimental dermatology.

[7]  I. Gigli,et al.  Histamine release from rodent and human mast cells induced by protoporphyrin and ultraviolet light: studies of the mechanism of mast‐cell activation in erythropoietic protoporphyria , 1990, The British journal of dermatology.

[8]  P. Collins,et al.  Randomized, double‐blind, placebo‐controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2·5% and prilocaine 2·5% for topical 5‐aminolaevulinic acid–photodynamic therapy for extensive scalp actinic keratoses , 2006, The British journal of dermatology.

[9]  M. Goldman,et al.  Comparative benefit of two thermal spring waters after photodynamic therapy procedure , 2007, Journal of cosmetic dermatology.

[10]  H. Wulf,et al.  Photodynamic therapy of acne vulgaris using methyl aminolaevulinate: a blinded, randomized, controlled trial , 2006, The British journal of dermatology.

[11]  A. Wennberg,et al.  Topical methyl aminolaevulinate photodynamic therapy for treatment of facial acne vulgaris: results of a randomized, controlled study , 2006, The British journal of dermatology.

[12]  Christian Gluud,et al.  Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial , 2000, The Lancet.

[13]  C. A. Thissen,et al.  Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. , 2006, Journal of drugs in dermatology : JDD.

[14]  P Lehmann,et al.  Preferential Relative Porphyrin Enrichment in Solar Keratoses upon Topical Application of ^‐Aminolevulinic Acid Methylester , 1998, Photochemistry and photobiology.

[15]  Mônica Manela-Azulay,et al.  Terapia fotodinâmica: revisão da literatura e documentação iconográfica , 2010 .

[16]  J. Ring,et al.  Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid. , 2006, Journal of drugs in dermatology : JDD.

[17]  M. Alexiades-Armenakas.  Laser-mediated photodynamic therapy. , 2006, Clinics in dermatology.

[18]  Michael S. Patterson,et al.  Calculation of Singlet Oxygen Dose from Photosensitizer Fluorescence and Photobleaching During mTHPC Photodynamic Therapy of MLL Cells¶ , 2005 .

[19]  D. Leff,et al.  The effect of local cooling on pain perception during infiltration of local anaesthetic agents, a prospective randomised controlled trial * , 2007, Anaesthesia.

[20]  M. Landthaler,et al.  Disappointing results and low tolerability of photodynamic therapy with topical 5‐aminolaevulinic acid in psoriasis. A randomized, double‐blind phase I/II study , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[21]  O Larkö,et al.  Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome , 2004, The British journal of dermatology.

[22]  C. Whitehurst,et al.  Comparison of red and green light in the treatment of Bowen’s disease by photodynamic therapy , 2000, The British journal of dermatology.

[23]  E. Neuzil,et al.  Calcium and bicarbonate ions mediate the inhibition of mast cell histamine release by Avène spa water , 2000, Fundamental & clinical pharmacology.

[24]  C. F. Neto,et al.  Terapia fotodinâmica em dermatologia: princípios básicos e aplicações , 2009 .

[25]  Harald Kittler,et al.  Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study. , 2005, Journal of the American Academy of Dermatology.

[26]  M. Tominaga,et al.  Increased sensitivity of desensitized TRPV1 by PMA occurs through PKCepsilon-mediated phosphorylation at S800. , 2006, Pain.

[27]  H. Wulf,et al.  Cold water and pauses in illumination reduces pain during photodynamic therapy: a randomized clinical study. , 2009, Acta dermato-venereologica.

[28]  Thomas H Foster,et al.  Irradiance-Dependent Photobleaching and Pain in δ-Aminolevulinic Acid-Photodynamic Therapy of Superficial Basal Cell Carcinomas , 2008, Clinical Cancer Research.

[29]  Barbara A Gilchrest,et al.  A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. , 2004, Archives of dermatology.

[30]  Carin Sandberg,et al.  Important factors for pain during photodynamic therapy for actinic keratosis. , 2006, Acta dermato-venereologica.

[31]  M. Landthaler,et al.  Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial. , 2007, The British journal of dermatology.

[32]  Michael S Patterson,et al.  Calculation of Singlet Oxygen Dose from Photosensitizer Fluorescence and Photobleaching During mTHPC Photodynamic Therapy of MLL Cells ¶ , 2005, Photochemistry and photobiology.

[33]  K. Mckenna,et al.  Guidelines for Topical Photodynamic Therapy: Update. On behalf of the British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group. , 2008 .

[34]  M. Tominaga,et al.  Increased sensitivity of desensitized TRPV1 by PMA occurs through PKCε-mediated phosphorylation at S800 , 2006, Pain.

[35]  Bernd Nilius,et al.  The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels , 2004, Nature.

[36]  A Tanew,et al.  Topical aminolaevulinic acid‐based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer‐blinded study , 2005, The British journal of dermatology.

[37]  Terapêutica fotodinâmica com ácido delta-aminole- vulínico em neoplasias queratinocíticas superficiais * Photodynamic therapy with delta-aminolevulinic acid for superficial keratinocytic neoplasms * , 2003 .

[38]  C. Morton,et al.  Guidelines for topical photodynamic therapy: update , 2008, The British journal of dermatology.

[39]  F. Moloney,et al.  Randomized, double‐blind, prospective study to compare topical 5‐aminolaevulinic acid methylester with topical 5‐aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis , 2007, The British journal of dermatology.

[40]  Hans Christian Wulf,et al.  Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin. , 2003, Archives of dermatology.

[41]  Cold Air Analgesia in Photodynamic Therapy of Basal Cell Carcinomas and Bowenʼs Disease: An Effective Addition to Treatment , 2004 .

[42]  Carola Berking,et al.  Effect of Subcutaneous Infiltration Anesthesia on Pain in Photodynamic Therapy: A Controlled Open Pilot Trial , 2007, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[43]  V. von Felbert,et al.  Photodynamic therapy of multiple actinic keratoses: reduced pain through use of visible light plus water‐filtered infrared A compared with light from light‐emitting diodes , 2010, The British journal of dermatology.

[44]  G. Jemec,et al.  Pain and Photodynamic Therapy , 2007, Dermatology.

[45]  H. Wulf,et al.  Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate , 2008, The British journal of dermatology.

[46]  S. Campbell,et al.  The effect of air cooling pain relief on protoporphyrin IX photobleaching and clinical efficacy during dermatological photodynamic therapy. , 2011, Journal of photochemistry and photobiology. B, Biology.

[47]  H. Wulf,et al.  Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single‐blinded study , 2008, The British journal of dermatology.

[48]  S. Ibbotson,et al.  A randomized, double‐blind, placebo‐controlled study of the efficacy of tetracaine gel (Ametop®) for pain relief during topical photodynamic therapy , 2004, The British journal of dermatology.

[49]  S. Ibbotson,et al.  Topical 5‐aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources , 2003, Photodermatology, photoimmunology & photomedicine.

[50]  T. Ruzicka,et al.  Green light is effective and less painful than red light in photodynamic therapy of facial solar keratoses , 1997, Photodermatology, photoimmunology & photomedicine.

[51]  H. Wulf,et al.  Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. , 2006, Journal of the American Academy of Dermatology.

[52]  J. Moan,et al.  Topical aminolaevulinic acid‐ and aminolaevulinic acid methyl ester‐based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema , 2009, The British journal of dermatology.

[53]  R. Botella-Estrada,et al.  Comparative study between cold air analgesia and supraorbital and supratrochlear nerve block for the management of pain during photodynamic therapy for actinic keratoses of the frontotemporal zone , 2009, The British journal of dermatology.

[54]  Z. Malik,et al.  Temperature monitoring during photodynamic therapy of skin tumors with topical 5-aminolevulinic acid application. , 1995, Cancer letters.

[55]  J. Paoli,et al.  Nerve blocks provide effective pain relief during topical photodynamic therapy for extensive facial actinic keratoses , 2008, Clincal and Experimental Dermatology.